31-45 of 50
Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates
CME/CE Broadcast ReplayRisk Assessment in Pulmonary Hypertension: Practice Trends and Updates
Robert P. Frantz, MD, FACC
Vallerie V. McLaughlin, MD
Sonja Bartolomei, MD
Pulmonary Hypertension for Advanced Practice Providers: Risk Stratification and Diagnosis to Enhance Quality of Care and Outcomes
CME/CE Broadcast ReplayPulmonary Hypertension for Advanced Practice Providers: Risk Stratification and Diagnosis to Enhance Quality of Care and Outcomes
Martha Kingman, DNP, FNP-C
Susanne McDevitt, DNP, ACNP-BC
Updates From the 7th World Symposium Task Force
CME/CEUpdates From the 7th World Symposium Task Force
Eric D. Austin, MD, MSCI
Hilary M. DuBrock, MD
H. James Ford, MD
Gustavo A. Heresi, MD, MS
Gergely Meszaros, JD, MSc
Oksana A. Shlobin, MD
Ioana Preston, MD
Lucilla Piccari, MD, PhD
Gilberto de Lima Lopes, Jr, MD, MBA, FASCO
Jyoti Patel, MD
Kelly Chin, MD, MSCA
Macitentan Update: Impact on Management of Pulmonary Hypertension
MinuteCE®Macitentan Update: Impact on Management of Pulmonary Hypertension
Richard N. Channick, MD
- advertisement
Ioana Preston, MD
Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension
MinuteCE®Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension
Vallerie V. McLaughlin, MD
Richard Krasuski, MD
Richard N. Channick, MD
Vallerie V. McLaughlin, MD
Ioana Preston, MD
Kelly Chin, MD, MSCA
Richard Krasuski, MD
Updates on Pulmonary Hypertension Clinical Trials
MinuteCE®Updates on Pulmonary Hypertension Clinical Trials
Vallerie V. McLaughlin, MD
Advances in Minimally Invasive Screening for Lung Cancer
CME/CEAdvances in Minimally Invasive Screening for Lung Cancer
Julie A. Barta, MD, ATSF
Peter J. Mazzone, MD, MPH, FCCP
- advertisement
Expert Answers to Common Questions About MET Exon 14–Skipping Mutations in NSCLC
CME/CEExpert Answers to Common Questions About MET Exon 14–Skipping Mutations in NSCLC
Mark Socinski, MD
Patrick Forde, M.B.B.Ch.
Karen Reckamp, MS, MD
TROP2 ADCs for Metastatic NSCLC: Setting the Stage for Future Use
CME/CETROP2 ADCs for Metastatic NSCLC: Setting the Stage for Future Use
Benjamin Levy, MD
Rebecca Heist, MD, MPH
Peter Bela Illei, MD
Clinical Reflections®: Reflecting on Missed Opportunities in Nontuberculous Mycobacteria Lung Disease
CME/CEClinical Reflections®: Reflecting on Missed Opportunities in Nontuberculous Mycobacteria Lung Disease
Anne O'Donnell, MD
Patrick Flume, MD
